Skip to main content Accessibility help
×
Hostname: page-component-77c89778f8-9q27g Total loading time: 0 Render date: 2024-07-16T21:56:43.310Z Has data issue: false hasContentIssue false

10 - Referral criteria for cancer genetics clinics

Published online by Cambridge University Press:  24 August 2009

Diana M. Eccles
Affiliation:
Princess Anne Hospital, Southampton, UK
Patrick J. Morrison
Affiliation:
Belfast City Hospital, Belfast
Shirley V. Hodgson
Affiliation:
Guy's Hospital, London
Neva E. Haites
Affiliation:
University of Aberdeen
Get access

Summary

Introduction

Setting criteria for referral to a clinic requires a clear view of the purpose of the clinic for which the criteria are being set. This chapter will review the current approaches to assessing and managing breast cancer risk and will attempt to put these approaches into the context of the available evidence regarding clinical effectiveness.

Background

Primary care and breast cancer units have found themselves besieged by women who are worried about their risk of breast cancer. The origins of this worry may be media driven, family driven or physician driven and may be appropriate (in those at high genetic risk) or inappropriate. In response to public demand for risk management options, many ‘family history’ clinics have sprung up throughout western Europe, offering breast screening to women who present with concerns about breast cancer risk, usually in this circumstance based on a family history of the disease. Breast screening mammograms with or without physical examination are the measures usually aimed at early breast cancer detection. There are no large scale randomized trials of breast screening in women who are under 50 years of age and at increased genetic risk of breast cancer. There are a small number of reported cohort studies involving relatively small numbers that indicate that breast cancer can be successfully detected at early stages in women under 50 who undergo regular screening examinations (Kollias et al., 1998; Lalloo et al., 1998; Møller et al., 1998; Kerlikowske et al., 2000; Tilanus-Linthorst et al., 2000).

Type
Chapter
Information
Familial Breast and Ovarian Cancer
Genetics, Screening and Management
, pp. 157 - 165
Publisher: Cambridge University Press
Print publication year: 2002

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×